Personalized Therapy

SonoClear Study Selected for EANS 2026 Oral Presentation

OSLO, Norway, June 16, 2026 SonoClear AS has announced that findings from its pivotal multicenter study evaluating the SonoClear®...

By cGxPwire Editor
June 17, 2026

MedTech

Nervonik Completes First Human Nerve Sensing Study

LOS ANGELES, June 16, 2026 Nervonik Inc., a clinical-stage medical device company focused on next-generation neuromodulation technologies, has announced...

By cGxPwire Editor
June 17, 2026

.Clinical Bio-Pharma

Foresight Diagnostics Demonstrates Ultrasensitive MRD Detection in Early-Stage Lung Cancer at IASLC 2025

Foresight Diagnostics, a leader in ultrasensitive minimal residual disease (MRD) detection, presented new clinical performance data on its Foresight...